HSINCHU, TAIWAN – October 20, 2015— JHL Biotech (TWEM: 6540), an emerging biosimilars company in Taiwan and China, announced today that Max Chan will join the company as Chief Financial Officer... read more →
HSINCHU, TAIWAN – October 2, 2015—JHL Biotech (TWEM: 6540), an emerging biosimilars company incorporated in Cayman Islands and based in Taiwan and China, announced today it has been publicly listed... read more →
HSINCHU, TAIWAN – September 28, 2015—JHL Biotech, an emerging biosimilars company in Taiwan, hosted a delegation of Brazilian government officials and topranking biotech executives who visited the company’s headquarters in... read more →
HSINCHU, TAIWAN – May 18, 2015 – JHL Biotech, Inc., an emerging biopharmaceutical development organization with integrated manufacturing capability, today announced that it has successfully completed the GMP manufacture and... read more →
HSINCHU, TAIWAN – May 11, 2015 – JHL Biotech, Inc., an emerging biopharmaceutical company, today announced that it has closed a Series C fundraising of $45.6 million, led by funds... read more →